GeneOne Life Science
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Soeul, Ch'ungch'ong-namdo, South KoreaWebsite
www.genels.comRevenue
$5.6 MillionIndustry
About GeneOne Life Science
GeneOne Life Science Org Chart
Is GeneOne Life Science your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
GeneOne Life Science, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on GeneOne Life Science recently announced quarterly report
Click to see if GeneOne Life Science had a recent Job posting/layoffs
Product Launch: Get notified when GeneOne Life Science launches new products
Congratulate Masked Content for being promoted to Masked Content at GeneOne Life Science
Funding: Get notified immidiatlly once GeneOne Life Science has new funding data
Check if GeneOne Life Science has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if GeneOne Life Science is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at GeneOne Life Science
Find 3 more new buyers
Company Profile Activity
Activity Insights
GeneOne Life Science is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GeneOne Life Science is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GeneOne Life Science.
GeneOne Life Science Tech Stack
A closer look at the technologies used by GeneOne Life Science
GeneOne Life Science News & Media
VGXI accepted as a Member of the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium
CONROE, Texas, Aug. 20, 2024 /PRNewswire/ -- VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, is honored to announce its acceptance into the Biopharmaceutical...VGXI, accepted as a Member of the US Government's Rapid Response Partnership Vehicle (RRPV)
CONROE, Texas, July 30, 2024 /PRNewswire/ -- VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, is proud to announce its selection as a member of Rapid Response...VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
CONROE, Texas, June 3, 2024 /PRNewswire/ -- VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, has entered into a strategic partnership with Sutro Biopharma, Inc....Stephanie Burke Named as VGXI's New Chief Accounting Officer
CONROE, Texas, March 27, 2024 /PRNewswire/ -- VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, is pleased to announce the appointment of Stephanie Burke as the Chief...
Top Business Services Companies
Frequently Asked Questions Regarding GeneOne Life Science
진원생명과학(주) is a biopharmaceutical research and development company specializing in the development and contract manufacturing of nucleic acid-based biopharmaceuticals, including DNA and RNA vaccines. The company focuses on innovative solutions for preventing emerging infectious diseases and developing anti-inflammatory small molecule drugs. With aut... Read More